The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|25|4218-4238

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.25, 2012-09, pp. : 4218-4238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ellipticines as DNA-Targeted Chemotherapeutics

By  

Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-01 ,pp. : 575-591

Bentham Science Publishers

Access to resources Recommend Favorite

Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 4, 2012-02 ,pp. : 475-487

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Discovery of Macrocyclic Histone Deacetylase Inhibitors for the Treatment of Cancer

By  

Current Medicinal Chemistry, Vol. 24, Iss. 37, 2017-12 ,pp. : 4166-4179

Bentham Science Publishers

Access to resources Recommend Favorite

An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors

By  

Current Cancer Drug Targets, Vol. 12, Iss. 4, 2012-04 ,pp. : 439-452

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors for the Treatment of Colorectal Cancer: Recent Progress and Future Prospects

By  

Current Cancer Drug Targets, Vol. 17, Iss. 5, 2017-05 ,pp. : 456-466

Bentham Science Publishers

Access to resources Recommend Favorite